{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:58:20Z","timestamp":1784231900064,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4016-1","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:03:09Z","timestamp":1557309789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient"],"prefix":"10.1186","volume":"19","author":[{"given":"Susanne","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stamminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2188-1815","authenticated-orcid":false,"given":"Detlef","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"4016_CR1","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427\u201338.","journal-title":"Blood"},{"key":"4016_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","volume":"25","author":"P Ljungman","year":"2011","unstructured":"Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am. 2011;25:151\u201369.","journal-title":"Hematol Oncol Clin North Am"},{"key":"4016_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","volume":"118","author":"JM Goodrich","year":"1993","unstructured":"Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med. 1993;118:173\u20138.","journal-title":"Ann Intern Med"},{"key":"4016_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010;10:1228\u201337.","journal-title":"Am J Transplant"},{"key":"4016_CR5","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","volume":"113","author":"M Boeckh","year":"2009","unstructured":"Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood. 2009;113:5711\u20139.","journal-title":"Blood"},{"key":"4016_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1517\/14656560802678138","volume":"10","author":"A Schreiber","year":"2009","unstructured":"Schreiber A, Harter G, Schubert A, Bunjes D, Mertens T, Michel D. Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother. 2009;10:191\u2013209.","journal-title":"Expert Opin Pharmacother"},{"key":"4016_CR7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/135965350801300504","volume":"13","author":"G Champier","year":"2008","unstructured":"Champier G, Couvreux A, Hantz S, Rametti A, Mazeron MC, Bouaziz S, Denis F, Alain S. Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. Antivir Ther. 2008;13:643\u201354.","journal-title":"Antivir Ther"},{"key":"4016_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/AAC.01596-09","volume":"54","author":"P Lischka","year":"2010","unstructured":"Lischka P, Hewlett G, Wunberg T, Baumeister J, Paulsen D, Goldner T, Ruebsamen-Schaeff H, Zimmermann H. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother. 2010;54:1290\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4016_CR9","doi-asserted-by":"publisher","first-page":"10884","DOI":"10.1128\/JVI.05265-11","volume":"85","author":"T Goldner","year":"2011","unstructured":"Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol. 2011;85:10884\u201393.","journal-title":"J Virol"},{"key":"4016_CR10","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Letermovir prophylaxis for Cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377:2433\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jmv.2003","volume":"65","author":"D Michel","year":"2001","unstructured":"Michel D, H\u00f6hn S, Haller T, Jun D, Mertens T. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. J Med Virol. 2001;65(1):70\u20136.","journal-title":"J Med Virol"},{"key":"4016_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/femsre\/fuy004","volume":"42","author":"G Ligat","year":"2018","unstructured":"Ligat G, Czal R, Hantz S, Alain S. The human cytomegalovirus terminase complex as an antiviral target: a close-up view. FEMS Microbiol Rev. 2018;42:137\u201345.","journal-title":"FEMS Microbiol Rev"},{"key":"4016_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.coph.2008.07.002","volume":"8","author":"P Lischka","year":"2008","unstructured":"Lischka P, Zimmermann H. Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Curr Opin Pharmacol. 2008;8:541\u20138.","journal-title":"Curr Opin Pharmacol"},{"key":"4016_CR14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","volume":"370","author":"RF Chemaly","year":"2014","unstructured":"Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornh\u00e4user M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, K\u00f6lling K, Stobernack HP, Lischka P, Zimmermann H, R\u00fcbsamen-Schaeff H, Champlin RE, Ehninger G. AIC246 Study Team. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014;370:1781\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"e2019001","DOI":"10.4084\/MJHID.2019.001","volume":"11","author":"JJ Frietsch","year":"2019","unstructured":"Frietsch JJ, Michel D, Stamminger T, Hunstig F, Birndt S, Schnetzke U, Scholl S, Hochhaus A, Hilgendorf I. In vivo emergence of UL56 C325Y Cytomegalovirus resistance to Letermovir in a patient with acute myeloid leukemia after hematopoietic cell transplantation. Mediterr J Hematol Infect Dis. 2019;11(1):e2019001. https:\/\/doi.org\/10.4084\/MJHID.2019.001 eCollection 2019.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4016_CR16","doi-asserted-by":"publisher","unstructured":"Turner N, Strand A, Grewal DS, Cox G, Arif S, Baker AW, Maziarz EK, Saullo JH, Wolfe CR. Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.02337-18 [Epub ahead of print].","DOI":"10.1128\/AAC.02337-18"},{"key":"4016_CR17","doi-asserted-by":"publisher","unstructured":"Knoll BM, Seiter K, Phillips A, Soave R. Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis. Bone Marrow Transplant. 2018. https:\/\/doi.org\/10.1038\/s41409-018-0389-9 . [Epub ahead of print].","DOI":"10.1038\/s41409-018-0389-9"},{"issue":"12","key":"4016_CR18","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1111\/ajt.15135","volume":"18","author":"L Cherrier","year":"2018","unstructured":"Cherrier L, Nasar A, Goodlet KJ, Nailor MD, Tokman S, Chou S. Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection. Am J Transplant. 2018;18(12):3060\u20134. https:\/\/doi.org\/10.1111\/ajt.15135 Epub 2018 Oct 29.","journal-title":"Am J Transplant"},{"key":"4016_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/jiv352","volume":"213","author":"P Lischka","year":"2016","unstructured":"Lischka P, Michel D, Zimmermann H. Characterization of Cytomegalovirus breakthrough events in a phase 2 prophylaxis trial of Letermovir (AIC246, MK 8228). J Infect Dis. 2016;213:23\u201330.","journal-title":"J Infect Dis"},{"key":"4016_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cpdd.388","volume":"7","author":"D Kropeit","year":"2017","unstructured":"Kropeit D, von Richter O, Stobernack HP, R\u00fcbsamen-Schaeff H, Zimmermann H. Pharmacokinetics and safety of Letermovir Coadministered with cyclosporine a or tacrolimus in healthy subjects. Clin Pharm Drug Dev. 2017;7:9\u201321.","journal-title":"Clin Pharm Drug Dev"},{"key":"4016_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1128\/AAC.01794-13","volume":"58","author":"T Goldner","year":"2014","unstructured":"Goldner T, Hempel C, Ruebsamen-Schaeff H, Zimmermann H, Lischka P. Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure. Antimicrob Agents Chemother. 2014;58:610\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"4016_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","volume":"28","author":"S Chou","year":"2015","unstructured":"Chou S. Approach to drug-resistant cytomegalovirus in transplant recipients. Curr Opin Infect Dis. 2015;28:293\u20139.","journal-title":"Curr Opin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4016-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T15:20:31Z","timestamp":1663428031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4016-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.M. was consultant for virological diagnosis for AiCuris GmbHCo.KG. The authors have received no funding for the preparation of this manuscript. The authors declare that they have no conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"388"}}